CoLo-ID
1+
Downloads
Everyone
info
About this app
Over the past several years, it has been clearly demonstrated that patient management in colonoscopy can be optimized — both economically and environmentally — by refraining from systematically submitting all resected colonic polyps for histopathological examination, provided that these polyps meet specific visual and dimensional criteria.
Despite this proven benefit and the publication of international recommendations by the American Society for Gastrointestinal Endoscopy (ASGE, 2014) and the European Society of Gastrointestinal Endoscopy (ESGE, 2022), the practical implementation of selective histopathological analysis (Resect-and-Discard and Diagnose-and-Leave strategies) remains limited.
This gap between recommendations and clinical practice is primarily due to the challenges associated with the training, certification, and objective evaluation of endoscopists’ ability to characterize polyps accurately. Furthermore, even with the integration of artificial intelligence (AI), current systems still fall short of the reliability thresholds required by professional societies.
Colo-ID has been developed to address these unmet needs. The application provides a comprehensive training and assessment platform designed for endoscopists. It includes a learning module and an interactive training environment that allow users to review a large number of annotated endoscopic images and to evaluate their diagnostic accuracy, characterization skills, and therapeutic decision-making performance.
Additionally, Colo-ID quantifies and displays the potential economic savings and carbon footprint reduction associated with the application of the Resect-and-Discard and Diagnose-and-Leave approaches.
Finally, the platform also supports the creation and continuous enrichment of a structured database linking endoscopic image features with corresponding histopathological findings.
This resource will contribute to the development and training of AI-based decision-support algorithms, with the long-term goal of improving the accuracy, safety, and sustainability of colorectal cancer prevention strategies.
Despite this proven benefit and the publication of international recommendations by the American Society for Gastrointestinal Endoscopy (ASGE, 2014) and the European Society of Gastrointestinal Endoscopy (ESGE, 2022), the practical implementation of selective histopathological analysis (Resect-and-Discard and Diagnose-and-Leave strategies) remains limited.
This gap between recommendations and clinical practice is primarily due to the challenges associated with the training, certification, and objective evaluation of endoscopists’ ability to characterize polyps accurately. Furthermore, even with the integration of artificial intelligence (AI), current systems still fall short of the reliability thresholds required by professional societies.
Colo-ID has been developed to address these unmet needs. The application provides a comprehensive training and assessment platform designed for endoscopists. It includes a learning module and an interactive training environment that allow users to review a large number of annotated endoscopic images and to evaluate their diagnostic accuracy, characterization skills, and therapeutic decision-making performance.
Additionally, Colo-ID quantifies and displays the potential economic savings and carbon footprint reduction associated with the application of the Resect-and-Discard and Diagnose-and-Leave approaches.
Finally, the platform also supports the creation and continuous enrichment of a structured database linking endoscopic image features with corresponding histopathological findings.
This resource will contribute to the development and training of AI-based decision-support algorithms, with the long-term goal of improving the accuracy, safety, and sustainability of colorectal cancer prevention strategies.
Updated on
Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
No data shared with third parties
Learn more about how developers declare sharing
This app may collect these data types
Personal info, Messages and 2 others
Data is encrypted in transit
You can request that data be deleted
What’s new
Colo-ID – Colonic Polyp Characterization Training
App support
About the developer
ANAMORPHIK STUDIO
info@anamorphik.com
165 AVENUE ANDRE MALRAUX
54600 VILLERS LES NANCY
France
+33 7 55 53 35 87